Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model

Kevin A Guttenplan1,2, Maya K Weigel3, Drew I Adler4

  • 1Department of Neurobiology, School of Medicine, Stanford University, Stanford, 94305, CA, USA. kguttenp@stanford.edu.

Nature Communications
|July 29, 2020
PubMed

Related Concept Videos